CRC Research Update — June 06, 2026
Today's colorectal cancer research highlights
ras
A collection of 50 issues
CRC Research Update — June 01, 2026
Today's colorectal cancer research highlights
This Week in CRC Research — May 31, 2026
Weekly colorectal cancer research intelligence
Phase 2 trial tests fruquintinib plus chemotherapy in RAS-mutant CRC
Skip to content
The CRC Digest
◆ TRIAL DATA
Phase 2 trial tests fruquintinib plus chemotherapy in RAS-mutant CRC — Journal of Clinical Oncology
A multicenter, open-label phase 2 study evaluated fruquintinib (a targeted therapy) combined with FOLFIRI or mFOLFOX6 chemotherapy as second-line treatment for patients with RAS-mutant metastatic colorectal cancer. RAS
CRC Research Update — May 29, 2026
Today's colorectal cancer research highlights
CRC Research Update — May 25, 2026
Today's colorectal cancer research highlights
RAS/BRAF wild-type patients: Maintenance strategies compared
Skip to content
The CRC Digest
RAS/BRAF wild-type patients: Maintenance strategies compared
Three trials pooled data on left-sided, RAS/BRAF wild-type metastatic CRC to compare toxicity profiles of different maintenance approaches. (Journal of the National Cancer Institute)
This content is informational only and does not constitute medical advice.
Always
CRC Research Update — May 13, 2026
Today's colorectal cancer research highlights
CRC Research Update — May 12, 2026
Today's colorectal cancer research highlights
CRC Research Update — April 06, 2026
Today's colorectal cancer research highlights